Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CI 920

Known as: CI-920 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Catalytic asymmetric synthesis of the natural antibiotic fostriecin (CI-920) and its analogue 8-epi-fostriecin and evaluation of… Expand
2004
2004
SummaryBiochemical studies on a new antitumor antibiotic, CI-920, have been directed toward understanding its mode of action. The… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
2003
2003
The total synthesis of an antitumor antibiotic, fostriecin (CI-920), via a highly convergent route is described. A characteristic… Expand
2002
2002
Fostriecin, a potent and promising antitumor antibiotic, was stereoselectively synthesized via a convergent route involving a… Expand
Highly Cited
2001
Highly Cited
2001
Fostriecin (CI-920, 1; see Scheme 1) is a structurally interesting antitumor agent that was first isolated in 1983 by scientists… Expand
Highly Cited
1986
Highly Cited
1986
A human tumor cloning assay was utilized to evaluate the antineoplastic activity of the novel antitumor antibiotic fostriecin (CI… Expand
1985
1985
CI-920 is a structurally novel, phosphate-containing polyene lactone antitumor agent isolated from a previously undescribed… Expand
Highly Cited
1984
Highly Cited
1984
Cl-920 is a structurally novel phosphate ester antibiotic that contains an unsaturated lactone and a conjugated triene system. It… Expand
Highly Cited
1983
Highly Cited
1983
A complex of structurally related compounds that exhibit in vivo antileukemic activity was isolated from fermentation broths of a… Expand
Highly Cited
1983
Highly Cited
1983
CI-920 (PD 110,161) and two analogues (PD 113,270 and PD 113,271) are novel antitumor compounds produced by a new actinomycete… Expand